Delivery Order SPE2DB22D3004-SPE2DB25FSB26
- Not listed
- The Defense Logistics Agency awarded a $21,606.60 delivery order to AmerisourceBergen Drug Corp for ACT-O-Vials on September 5, 2025, with an ultimate completion date of September 8, 2025. This is a firm fixed-price, non-set-aside contract performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a small transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio and reflects the company's role as a critical vendor for military...
- The Defense Logistics Agency awarded a $7,146.61 firm fixed-price delivery order to AmerisourceBergen Drug Corp on April 22, 2025, for ACT-O-VIALS pharmaceutical supplies, with completion targeted for April 23, 2025. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $8,642.64 to AmerisourceBergen Drug Corp for ACT-O-VIALS on September 3, 2025, with completion expected by September 4, 2025. This firm fixed price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The work will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $9,949.28 to AmerisourceBergen Drug Corp for Act-O-Vials on September 18, 2025, with an ultimate completion date of September 19, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under a larger indefinite delivery vehicle. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. As a critical pharmaceutical distributor, AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $27,440.80 to AmerisourceBergen Drug Corp for Act-o-Vials on September 16, 2025, with completion targeted for September 17, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $5,100.66 to AmerisourceBergen Drug Corp for Act-O-Vials on September 17, 2025, with an ultimate completion date of September 18, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The award was made on a competitive basis with no set-aside designation. Performance will occur at the contractor's Corporate Office location...
- The Defense Logistics Agency awarded a $173,475.80 delivery order to AmerisourceBergen Drug Corp for Act-O-Vials on September 4, 2025, with completion scheduled for September 5, 2025. This competitively awarded, firm fixed price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $6,963.84 to AmerisourceBergen Drug Corp on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order, issued under contract number 4569048102, represents a non-set-aside competitive award to the prime contractor. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $6,137.63 to AmerisourceBergen Drug Corp on August 21, 2025, with completion expected by August 22, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction within AmerisourceBergen's broader federal pharmaceutical supply operations. As a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, AmerisourceBergen fulfills critical medical...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order contract valued at $45,231.48 to AmerisourceBergen Drug Corp on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The order will be fulfilled from the vendor's Corporate Office location in Conshohocken, Pennsylvania....
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FSB26Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $6,693.29 to AmerisourceBergen Drug Corp for ACT-O-Vials on August 19, 2025, with an ultimate completion date of August 20, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded to the pharmaceutical distributor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction typical of AmerisourceBergen's extensive portfolio of federal medical supply deliveries, which predominantly support the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The contract supports critical healthcare needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 8/19/25 |